Quality of life after breast cancer: survivorship and sexuality

Breast Journal

Volumn 15, Issue 5, 2009, Pages 500-504

  Dizon, Don S ^a,b,c,d  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c Women and Infants Hospital of Rhode Island ^*

^d WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Breast cancer; Distress; Fertility; Sexual health; Survivorship

Indexed keywords

ALKYLATING AGENT; ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; PLACEBO; TESTOSTERONE;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DEPRESSION; DISTRESS SYNDROME; DYSPAREUNIA; FATIGUE; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYSTERECTOMY; LIFESTYLE MODIFICATION; PATIENT EDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL HEALTH; SEXUALITY; UROGENITAL TRACT DISEASE;

ANTI-ANXIETY AGENTS; AROUSAL; BREAST NEOPLASMS; COUNSELING; DYSPAREUNIA; ESTROGENS; FATIGUE; FEMALE; FERTILITY; HUMANS; ORGASM; QUALITY OF LIFE; SEXUALITY; STRESS, PSYCHOLOGICAL; SURVIVORS;

EID: 70449658064     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00766.x     Document Type: Article

References (21)

1. Aziz NM, Rowland JH. Trends and advances in cancer survivorship research: challenge and opportunity. Semin Radiât Oncol 2003;13:248-266
2. 2. Saquib N, Flatt SW, Natarajan L, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study. Breast Cancer Res Treat 2007;105:177-186 (Pubitemid 47366880)
3. Ng R, Better N, Green MD. Anticancer agents and cardiotoxicity. Semin Oncol 2006;33:2-14.
4. Perez EA. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer. Ann Oncol 2007;18(Suppl. 8):viii26-35.
5. 5. Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A. Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 2008;98:870-874 (Pubitemid 351341602)
6. 6. Bower JE. Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 2008;26:768-777 (Pubitemid 351264390)
7. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008; 26:753-758
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000.
9. Kornblith AB, Herndon JE, 2nd, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003;98:679-689
10. Holland JC, Andersen BL, Breitbard WS, et al. The NCCN Distress Management Clinical Practice Guidelines in Oncology (Version 1.2007). Available at http://www.nccn.org (accessed 8/2/2007), 2007.
11. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370
12. 12. Pinto BM, Frierson GM, Rabin C, Trunzo JJ, Marcus BH. Home-based physical activity intervention for breast cancer patients. ; Clin Oncol 2005;23:3577-3587 (Pubitemid 46243503)
13. 13. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. / Clin Oncol 2006;24:2917-2931 (Pubitemid 46655598)
14. Reh A, Oktem O, Oktay K. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers. Fertil Steril 2008;90: 1635-1639
15. Krychman ML. Sexual rehabilitation medicine in a female oncology setting. Gynecol Oncol 2006;101:380-384
16. 16. Wiggins DL, Wood R, Granai CO, Dizon DS. Sex, intimacy, and the gynecologic oncologist: survey results of the New England Association of Gynecologic Oncologists. J Psychosocial Oncol 2007; 25:61-70. (Pubitemid 350166023)
17. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-688
18. 18.FloterA,Nathorst-BoosJ,CarlstromK,vonSchoultzB.Additionoftestosterone- estrogenreplacementtherapyinoophorectomizedwomen:effectsonsexualityandwell- being.Climacteric2002;5:357-365(Pubitemid36149723)
19. 19. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2007;4(Suppl. 3):227-234 (Pubitemid 46372031)
20. Barton DL, Wender DB, Sloan JA, et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 2007;99:672-679
21. Stausmire JM. Sexuality at the end of life. Am J Hosp Palliât Care 2004;21:33-39